颅底与头颈部肉瘤诊疗专家共识(2024版)
颅底头颈部肉瘤起源于颅底和头颈部间质组织,高度侵袭性,可发生于所有年龄段。成人发病率不到头颈部肿瘤的1%,儿童中高达35%。中国抗癌协会肿瘤神经病学专业委员会等组织多学科专家研讨,基于循证医学证据,围绕流行病学、病理、影像、手术、放化疗、靶向及免疫治疗归纳临床应用推荐。
要点
- 成人颅底头颈部肉瘤罕见,发病率不到头颈部肿瘤的1%,儿童中高达35%。
- 病理类型主要包括脂肪肉瘤、血管肉瘤、平滑肌肉瘤、横纹肌肉瘤、尤文肉瘤、骨肉瘤、未分化多形性肉瘤。
- 治疗通常采用综合治疗策略,手术仍是首选治疗方案。
核心结论
- 中国尚无颅底头颈部肉瘤诊疗相关指南与共识,本共识基于循证医学证据归纳多学科临床应用推荐,旨在提升治疗水平、改善预后和生活质量。
研究设计与样本
- 由中国抗癌协会肿瘤神经病学专业委员会、中国医学教育协会头颈肿瘤专业委员会和中国医药教育协会肿瘤化学治疗专业青年委员会组织多学科专家研讨制定。
主要发现
- 成人颅底头颈部肉瘤发病率不到头颈部肿瘤的1%,儿童人群中发病率高达35%。
- 颅底头颈部肉瘤起源于颅底和头颈部间质组织,具有高度侵袭性,可发生于所有年龄段。
- 发病部位涉及颅底、面部和颈部的软组织、骨骼或神经,病理类型多样。
- 治疗通常采用综合治疗策略,手术仍是首选治疗方案,但手术难度大、放化疗疗效不一,整体治疗困难。
关键数值与推荐
- 共识归纳出流行病学、组织及分子病理、影像学、手术、放疗、化疗、靶向治疗、免疫治疗等诊疗方面的临床应用推荐。
临床怎么用
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Skull base sarcomas of the head and neck originate from the mesenchymal tissues of the skull base and head and neck region, exhibiting a highly aggressive behavior and can occur at all ages. Skull base sarcomas are rare in adults, with an incidence of less than 1% of head and neck tumors. However, in the pediatric population, the incidence can be as high as 35%. These tumors can arise in various locations, involving soft tissues, bones, or nerves of the skull base, face, and neck. The pathological types of skull base sarcomas are diverse, primarily including liposarcoma, angiosarcoma, leiomyosarcoma, rhabdomyosarcoma, Ewing sarcoma, osteosarcoma, undifferentiated pleomorphic sarcoma. Treatment typically involves a multimodal approach, with surgery being the preferred method. However, the surgical challenges posed by skull base sarcomas and the inconsistent efficacy of radiotherapy and chemotherapy contribute to the overall difficulty in treatment. Currently, there are no established guidelines or consensus for the diagnosis and management of skull base sarcomas in China. In response, Chinese Anti-Cancer Association Cancer Neurology Committee, Chinese Medical Education Association Head and Neck Oncology Professional Committee and Chinese Medical Education Association Oncology Chemotherapy Youth Committee have organized multidisciplinary expert discussions. Based on evidence from clinical research, we have summarized clinical application recommendations in the areas of epidemiology, histopathology, molecular pathology, imaging, surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy, with the aim of providing clinical practice evidence to enhance the treatment of skull base sarcomas and improve patient prognosis and quality of life. 颅底头颈部肉瘤起源于颅底和头颈部的间质组织,具有高度侵袭性,可发生于所有年龄段。成人颅底头颈部肉瘤罕见,发病率不到头颈部肿瘤的1%,但在儿童人群中,颅底头颈部肉瘤发病率高达35%。头颈部肉瘤发病部位分布广泛,涉及颅底、面部和颈部的软组织、骨骼或神经。颅底头颈部肉瘤的病理类型多样,主要包括脂肪肉瘤、血管肉瘤、平滑肌肉瘤、横纹肌肉瘤、尤文肉瘤、骨肉瘤、未分化多形性肉瘤。治疗通常采用综合治疗策略,手术仍是首选治疗方案。但因颅底头颈部肉瘤手术难度大,放化疗疗效不一,整体治疗困难,目前中国尚无颅底头颈部肉瘤诊疗相关的指南与共识。为此,中国抗癌协会肿瘤神经病学专业委员会、中国医学教育协会头颈肿瘤专业委员会和中国医药教育协会肿瘤化学治疗专业青年委员会组织多学科专家进行研讨,基于循证医学证据,归纳出流行病学、组织及分子病理、影像学、手术、放疗、化疗、靶向治疗、免疫治疗等诊疗方面的临床应用推荐,旨在提供临床实践证据,提升颅底头颈部肉瘤的治疗水平,改善患者的预后和生活质量。.
引用
- [The expert consensus on the diagnosis and treatment of skull base and head-neck sarcomas (2024 edition)]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 40113422. doi:10.3760/cma.j.cn112152-20240603-00235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。